Literature DB >> 23489974

Reporting positive surgical margins after radical prostatectomy: time for standardization.

Philip A Fontenot1, Ahmed M Mansour.   

Abstract

OBJECTIVES: To assess the consistency of reporting on positive surgical margins (PSMs) and associated prognostic variables after radical prostatectomy (RP) in the current literature To provide a standardized methodology for quantifying the characteristics and the prognostic impact of PSMs after RP. PATIENTS AND METHODS: We conducted a review of articles that assessed the prognostic value of characteristics of PSMs after RP. The articles were identified using a MEDLINE search. The methodology and quality of the reporting of PSMs were analysed according to six criteria defined according to the guidelines of the College of American Pathologists and the International Society of Uropathologists. Forty-four studies, involving ≥100 patients and published from January 2005 to the present, were reviewed.
RESULTS: Each of the 44 studies was assessed for their reporting of the six defined PSM criteria, as well as for the significance of PSM characteristics on biochemical recurrence (BCR). The definition of a PSM was the only criterion that was consistently reported. All studies were deficient in defining and reporting one or more of the PSM criteria. Major inconsistencies were observed in the reporting of PSM site and length, and the presence of intraprostatic incision. The many conflicting reports gave little insight into the true significance of particular PSM-associated variables on BCR.
CONCLUSIONS: There is a lack of consistency in the reporting on and prognostic significance of PSMs and PSM-associated prognostic variables. We hypothesize that these conflicting results are partly attributable to a lack of use of a standardized reporting methodology for PSMs. Implementation of a previously reported standardized scoring system for PSMs may help eliminate these inconsistencies in the future.
© 2013 BJU International.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23489974     DOI: 10.1111/j.1464-410X.2012.11640.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  13 in total

1.  Prevalence and risk factors of contralateral extraprostatic extension in men undergoing radical prostatectomy for unilateral disease at biopsy: A global multi-institutional experience.

Authors:  Marc Bienz; Pierre-Alain Hueber; Vincent Trudeau; Abdullah M Alenizi; Roger Valdivieso; Modar Alom; Mevlana Derya Balbay; Abdullah Erdem Canda; Vladimir Mouraviev; David M Albala; Assaad El-Hakim; Quoc-Dien Trinh; Mathieu Latour; Fred Saad; Kevin C Zorn
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

2.  Positive surgical margins after radical prostatectomy: What should we care about?

Authors:  Caroline Pettenati; Yann Neuzillet; Camelia Radulescu; Jean-Marie Hervé; Vincent Molinié; Thierry Lebret
Journal:  World J Urol       Date:  2015-05-05       Impact factor: 4.226

3.  Risk factors of positive surgical margins after robot-assisted radical prostatectomy in high-volume center: results in 732 cases.

Authors:  Antonio Benito Porcaro; Marco Sebben; Paolo Corsi; Alessandro Tafuri; Tania Processali; Marco Pirozzi; Nelia Amigoni; Riccardo Rizzetto; Giovanni Cacciamani; Arianna Mariotto; Alberto Diminutto; Matteo Brunelli; Vincenzo De Marco; Salvatore Siracusano; Walter Artibani
Journal:  J Robot Surg       Date:  2019-04-05

4.  Preoperative characteristics of the P.R.O.S.T.A.T.E. scores: a novel predictive tool for the risk of positive surgical margin after radical prostatectomy.

Authors:  Ben Xu; Cheng Luo; Qian Zhang; Jie Jin
Journal:  J Cancer Res Clin Oncol       Date:  2016-12-05       Impact factor: 4.553

5.  Tumor margin detection using quantitative NIRF molecular imaging targeting EpCAM validated by far red gene reporter iRFP.

Authors:  Banghe Zhu; Grace Wu; Holly Robinson; Nathaniel Wilganowski; Mary A Hall; Sukhen C Ghosh; Kenneth L Pinkston; Ali Azhdarinia; Barrett R Harvey; Eva M Sevick-Muraca
Journal:  Mol Imaging Biol       Date:  2013-10       Impact factor: 3.488

6.  Management of prostate cancer patients with locally adverse pathologic features after radical prostatectomy: feasibility of active surveillance for cases with Gleason grade 3 + 4 = 7.

Authors:  Xun Shangguan; Baijun Dong; Yanqing Wang; Fan Xu; Xiaoguang Shao; Jianjun Sha; Yinjie Zhu; Jiahua Pan; Wei Xue
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-20       Impact factor: 4.553

7.  The use of early postoperative prostate-specific antigen to stratify risk in patients with positive surgical margins after radical prostatectomy.

Authors:  Stepan Vesely; Ladislav Jarolim; Katerina Duskova; Marek Schmidt; Pavel Dusek; Marko Babjuk
Journal:  BMC Urol       Date:  2014-10-02       Impact factor: 2.264

8.  High surgeon volume and positive surgical margins can predict the risk of biochemical recurrence after robot-assisted radical prostatectomy.

Authors:  Antonio Benito Porcaro; Alessandro Tafuri; Marco Sebben; Nelia Amigoni; Tania Processali; Marco Pirozzi; Riccardo Rizzetto; Aliasger Shakir; Paolo Corsi; Leone Tiso; Clara Cerrato; Filippo Migliorini; Giovanni Novella; Matteo Brunelli; Riccardo Bernasconi; Vincenzo De Marco; Salvatore Siracusano; Walter Artibani
Journal:  Ther Adv Urol       Date:  2019-09-24

9.  Surgeon volume and body mass index influence positive surgical margin risk after robot-assisted radical prostatectomy: Results in 732 cases.

Authors:  Antonio B Porcaro; Alessandro Tafuri; Marco Sebben; Paolo Corsi; Tania Processali; Marco Pirozzi; Nelia Amigoni; Riccardo Rizzetto; Aliasger Shakir; Giovanni Cacciamani; Arianna Mariotto; Matteo Brunelli; Riccardo Bernasconi; Giovanni Novella; Vincenzo De Marco; Walter Artibani
Journal:  Arab J Urol       Date:  2019-05-30

10.  Surgical margin status and its impact on prostate cancer prognosis after radical prostatectomy: a meta-analysis.

Authors:  Lijin Zhang; Bin Wu; Zhenlei Zha; Hu Zhao; Jun Yuan; Yuefang Jiang; Wei Yang
Journal:  World J Urol       Date:  2018-05-15       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.